Inland Rheumatology and Osteoporosis Medical Group INC
Inland Rheumatology and Osteoporosis Medical Group INC was paid $4.95M by Medicaid between Jan 2018 and Nov 2024, across 34 billing codes. Its largest line is 99215, doctor's office visit, returning patient (complex) — 30% of everything it billed.
33Billing provider infoINLAND RHEUMATOLOGY AND OSTEOPOROSIS MEDICAL GROUP INC
UPLAND, CA 91786
UPLAND, CA 91786
33aNPI1437199882assigned 06/07/2006
33bProvider typeSpecialist
28Total paid$4.95M
24GClaims73,196
24DCodes billed34
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Specialist providers in California
Rank by total paid#48 of 1,230
Median peer was paid$51K
This provider vs. median96×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,124 | $717K | |
| 2019 | 10,894 | $758K | |
| 2020 | 9,668 | $602K | |
| 2021 | 9,410 | $657K | |
| 2022 | 9,852 | $737K | |
| 2023 | 12,183 | $799K | |
| 2024incomplete | 11,065 | $680K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 30% | 9,347 | 9,056 | $1.47M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 14,456 | 14,193 | $1.11M |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 11% | 896 | 818 | $528K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 8.6% | 689 | 629 | $427K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 7.5% | 4,099 | 3,805 | $373K |
| J3262 | Injection, tocilizumab, 1 mg | 6.4% | 939 | 569 | $317K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3.8% | 395 | 354 | $188K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.9% | 954 | 953 | $143K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.5% | 10,230 | 9,604 | $123K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.9% | 4,421 | 4,215 | $95K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,559 | 3,330 | $46K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,731 | 2,579 | $44K |
22 more codes
| 96415 | <1% | 1,205 | $27K | |
| 99205 | Prolong outpt/office vis | <1% | 93 | $18K |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 1,748 | $12K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 4,799 | $9K |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 2,020 | $6K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,014 | $4K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 8,292 | $3K |
| 20610 | <1% | 85 | $939.37 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 42 | $351.12 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 376 | $349.60 |
| 90674 | <1% | 47 | $348.95 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 527 | $251.92 |
| 99442 | <1% | 24 | $233.60 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 14 | $25.17 |
| G0008 | Administration of influenza virus vaccine | 0% | 28 | $0.00 |
| 85651 | 0% | 29 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 30 | $0.00 |
| 86140 | 0% | 12 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 25 | $0.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 28 | $0.00 |
| 90688 | 0% | 27 | $0.00 | |
| 90658 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEE, ERIC (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Jennie Stuart Medical Center INC | Hopkinsville, KY | $50.76M |
| Fairview Physicians Network LLC | Hopkinsville, KY | $4.36M |
| Fairview Physicians Network, LLC | Hopkinsville, KY | $685K |
| Jennie Stuart Medical Center | Hopkinsville, KY | $456K |
| Fairview Physicians Network, LLC | Hopkinsville, KY | $418K |
| Fairview Physicians Network, LLC | Hopkinsville, KY | $239K |
| Jennie Stuart Medical Center | Hopkinsville, KY | $230K |
| Eric Y. Lee, DDS, P.C. | Winchester, VA | $124K |
| Fairview Physicians Network, LLC | Trenton, KY | $80K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.